Analysis TetraLogic Pharmaceuticals Corporation (TLOG)
6/3/2024
Analysis of TetraLogic Pharmaceuticals Corporation (TLOG)
TetraLogic Pharmaceuticals Corporation (TLOG) has been trading at a consistent price of 0.00010 over the past several days, as indicated by the closing, opening, low, and high prices. Technical indicators such as RSI, MACD, and moving averages (SMA, EMA, WMA) are also showing stability with values around 0.00000 or 0.00010.Based on this data, it seems that TLOG has not experienced significant price movements or changes in technical indicators recently. This could indicate a period of consolidation or lack of significant market activity for the stock.
It would be important to monitor any upcoming news, developments, or market trends that could potentially impact TLOG's price and trading activity in the future.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $77,545,400,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 25.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $85,501,800,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 25.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $357,772,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 38.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $380,772,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 38.
These estimates indicate a moderate growth trend in both quarterly and annual sales for the company, with slightly higher growth expected in the next fiscal year compared to the current one.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.6%
- The next quarter growth rate is 5.1%
- The current quarter growth rate is 5.1%
- The next year growth rate is 9.7%
- The average annual growth rate for the next 5 years is 9.7%
- The average annual growth rate for the past 5 years is 20.1%
It can be observed that the company is expected to experience a significant decrease in growth rate compared to the past 5 years, with a notable drop from 20.1% to 9.7% for the next 5 years. Additionally, there is a slight increase in growth rate from the current year to the next year.
Price target
The analysts' forecast for the future price of the security is as follows:- Low: $164
- High: $275
- Median: $201.43
- Average: $204.58
- Current price: $192.25
- Currency: USD
Based on these forecasts, we can see that the current price of $192.25 is below both the median and average forecasted prices. The analysts' predictions suggest a potential increase in the price of the security, with a high estimate of $275. Investors may interpret this information as a signal that the security could be undervalued at its current price.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous quarter's results, ending on February 27, 2025, were handled by the Transfer Agent. The results for the quarter ending on January 31, 2025, were released after hours. The results for the quarter ending on October 31, 2024, were not provided at this time. However, for the quarter ending on August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provided includes financials, stock statistics, valuation metrics, stock price summary, and dividends and splits information for a specific company.In terms of financials, the company has strong operating cash flow and levered free cash flow, with a positive current ratio. The profit margin and operating margin are also healthy, indicating efficient operations. The company's fiscal year ends in September 2023, and it has shown positive returns on assets and equity.
Looking at stock statistics, the company has a low short ratio and a significant percentage of shares held by institutions. The stock price has fluctuated between a fifty-two-week low and high, with a positive change over the period.
Valuation metrics show a relatively high PEG ratio and price-to-book ratio, while the forward and trailing P/E ratios are moderate. The company's market capitalization and enterprise value are substantial, with reasonable price-to-sales and enterprise-to-EBITDA ratios.
The stock price summary includes beta, moving averages, and the range of prices over the past year.
Lastly, dividends and splits information reveals details about dividend rates, payout ratios, and historical split factors for the company's stock.
Income statement 💸
Here are the revenue figures for the company over the past four fiscal years:1. Fiscal Year 2023: Sales of $383,285,000,000
2. Fiscal Year 2022: Sales of $394,328,000,000
3. Fiscal Year 2021: Sales of $365,817,000,000
4. Fiscal Year 2020: Sales of $274,515,000,000
From these figures, we can observe the following trends:
- The company experienced a significant increase in sales from 2020 to 2022, followed by a slight decrease in 2023.
- Overall, there has been a positive revenue growth trend over the past four years, indicating the company's ability to generate increasing sales.
- It would be beneficial to further analyze the factors contributing to the fluctuations in revenue between the years to understand the company's performance better.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, from $323.9 billion in 2018 to $352.8 billion in 2023.
2. Current assets have fluctuated but generally increased, with the highest value in 2023 at $143.6 billion.
3. Non-current assets have also shown an increasing trend, reaching $209 billion in 2023.
4. Total liabilities have been increasing steadily, from $248 billion in 2019 to $290.4 billion in 2023.
5. Shareholders' equity has shown fluctuations but has generally increased, with the highest value in 2023 at $62.1 billion.
6. The company has been relying more on non-current assets to finance its operations, as seen in the increasing trend of non-current assets compared to current assets.
7. The company has been taking on more debt over the years, as indicated by the increasing total liabilities.
8. Despite the increase in liabilities, the company has managed to increase its shareholders' equity, indicating positive growth and financial health.
Cash Flow 💶
This is the cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value recorded in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. The end cash position has also been fluctuating, reaching its peak in 2020.
5. Financing activities show a pattern of common stock repurchase, issuance of long-term debt, and payment of dividends.
6. Investing activities include the sale and purchase of investments, as well as capital expenditures.
7. Overall, the company seems to be managing its cash flow effectively, with a focus on operational efficiency and strategic investments.
Earnings estimate
Based on the analysts' estimates for future quarterly and annual earnings per share:1. For the current quarter ending on June 30, 2024, the average estimated EPS is $1.23, with a range from $1.18 to $1.26. This shows an improvement compared to the EPS of $1.17 from the same quarter last year.
2. For the next quarter ending on September 30, 2024, the average estimated EPS is higher at $1.42, with a range from $1.33 to $1.51. This is also an increase from the EPS of $1.35 in the same quarter a year ago.
3. Looking at the estimates for the current fiscal year ending on September 30, 2024, the average EPS is projected to be $6.10, ranging from $5.95 to $6.41. This indicates growth from the EPS of $5.67 in the previous fiscal year.
4. For the next fiscal year ending on September 30, 2025, the average estimated EPS is $6.69, with a range from $5.92 to $7.31. This forecast suggests a slight improvement from the EPS of $6.10 in the current fiscal year.
Overall, the analysts' estimates show a positive outlook for the company's earnings per share, with expected growth in both the short term and the long term.
MACD of TLOG
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
